Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease. [electronic resource]
Producer: 20080808Description: 283-93 p. digitalISSN:- 1369-7056
- Adenoviridae -- genetics
- Animals
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Coronary Artery Disease -- genetics
- Drug Evaluation, Preclinical
- Fibroblast Growth Factor 4 -- adverse effects
- Genetic Therapy
- Genetic Vectors
- Humans
- Neovascularization, Physiologic -- genetics
- Patents as Topic
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.